CN Stock MarketDetailed Quotes
300361 Jiangsu Aosaikang Pharmaceutical
- 0.00
- 0.000.00%
Market Closed Sep 13 09:30 CST
0Market Cap0.00P/E (TTM)
0.00High0.00Low0lotVolume0.00Open0.00Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.0052wk High0.00P/B0Float Cap0.0052wk Low0.00Limit Up0Shs Float0.00Historical High0.00Limit Down0.00%Amplitude0.00Historical Low--Dividend TTM--Avg Price0lotAsk--Div YieldTTM100Lot Size0lotBid
Jiangsu Aosaikang Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2013 | (Q6)Jun 30, 2013 | (FY)Dec 31, 2012 | (Q9)Sep 30, 2012 | (FY)Dec 31, 2011 | (FY)Dec 31, 2010 | (FY)Dec 31, 2009 | |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||
| Goods sale service render cash | 40.92%2.25B | --1.39B | 61.04%2.29B | --1.6B | 54.94%1.42B | 33.30%918.49M | --689.02M |
| Refunds of taxes and levies | -74.19%78.28K | --72.09K | 0.65%455K | --303.33K | 5.44%452.08K | 16.70%428.75K | --367.4K |
| Cash received relating to other operating activities | 60.69%23.71M | --5.62M | -61.17%14.27M | --14.75M | 852.70%36.75M | -59.89%3.86M | --9.62M |
| Cash inflows from operating activities | 41.08%2.27B | --1.4B | 57.95%2.31B | --1.61B | 58.26%1.46B | 32.01%922.77M | --699M |
| Goods services cash paid | 93.54%185.57M | --126.17M | 35.12%166.86M | --95.88M | 26.13%123.49M | -6.08%97.91M | --104.25M |
| Staff behalf paid | 52.60%188.65M | --123.96M | 60.96%176.04M | --123.62M | 122.89%109.37M | 71.32%49.07M | --28.64M |
| All taxes paid | 28.45%363.26M | --225.54M | 67.35%389.92M | --282.79M | 67.72%232.99M | 62.98%138.92M | --85.24M |
| Cash paid relating to other operating activities | 35.59%1.21B | --746.7M | 52.92%1.33B | --888.88M | 49.70%870.65M | 33.33%581.59M | --436.21M |
| Cash outflows from operating activities | 39.64%1.94B | --1.22B | 54.45%2.06B | --1.39B | 54.07%1.34B | 32.57%867.49M | --654.34M |
| Net cash flows from operating activities | 50.19%330.1M | --177.16M | 95.76%242.41M | --219.79M | 124.00%123.83M | 23.79%55.28M | --44.66M |
| Investing cash flow | |||||||
| Cash received from disposal of investments | ---- | ---- | ---- | ---- | -82.04%11.65M | 7.72%64.87M | --60.22M |
| Cash received from returns on investments | ---- | ---- | ---- | ---- | ---- | 81.66%10.35K | --5.7K |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -79.50%100.6K | --100.6K | 9.63%491.12K | --490.62K | 307.27%448K | -39.13%110K | --180.72K |
| Cash received relating to other investing activities | 4,885.77%12.46M | --5.92M | -75.03%1.03M | --250K | --4.13M | ---- | --4.53M |
| Cash inflows from investing activities | 1,596.55%12.57M | --6.02M | -90.62%1.52M | --740.62K | -75.04%16.22M | 0.09%64.99M | --64.93M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 40.95%139.08M | --88.3M | 144.50%134.97M | --98.68M | 37.37%55.2M | 23.04%40.19M | --32.66M |
| Cash paid to acquire investments | ---- | ---- | ---- | ---- | -69.83%21.08M | 35.14%69.89M | --51.71M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | -63.14%6.58M | --6.58M | --17.85M | ---- | ---- |
| Cash paid relating to other investing activities | -15.41%6.77M | --2.32M | --9.31M | --8M | ---- | ---- | ---- |
| Cash outflows from investing activities | 28.78%145.85M | --90.62M | 60.26%150.86M | --113.26M | -14.48%94.13M | 30.46%110.07M | --84.37M |
| Net cash flows from investing activities | -18.46%-133.29M | ---84.59M | -91.69%-149.34M | ---112.52M | -72.80%-77.91M | -131.90%-45.09M | ---19.44M |
| Financing cash flow | |||||||
| Cash from borrowing | 1,000.00%110M | --80M | -21.43%110M | --10M | 380.63%140M | -38.34%29.13M | --47.24M |
| Cash inflows from financing activities | 1,000.00%110M | --80M | -21.43%110M | --10M | 380.63%140M | -38.34%29.13M | --47.24M |
| Borrowing repayment | --125M | --80M | 4.02%100M | ---- | 120.79%96.14M | -31.06%43.54M | --63.16M |
| Dividend interest payment | 119.61%68.38M | --66.68M | 555.58%33.09M | --31.14M | 202.44%5.05M | 54.43%1.67M | --1.08M |
| Cash payments relating to other financing activities | ---- | ---- | 307.33%6.11M | --5.86M | --1.5M | ---- | ---- |
| Cash outflows from financing activities | 422.68%193.38M | --146.68M | 35.56%139.2M | --37M | 127.12%102.69M | -29.62%45.21M | --64.24M |
| Net cash flows from financing activities | -208.84%-83.38M | ---66.68M | -178.26%-29.2M | ---27M | 331.98%37.31M | 5.38%-16.08M | ---17M |
| Net cash flow | |||||||
| Exchange rate change effecting cash and cash equivalents | -1,267.97%-4.95K | ---5.55K | 82.11%-174.18 | ---361.84 | 86.26%-973.36 | ---7.08K | ---- |
| Net increase in cash and cash equivalents | 41.30%113.43M | --25.88M | -23.27%63.87M | --80.28M | 1,512.14%83.24M | -171.72%-5.89M | --8.22M |
| Add:Begin period cash and cash equivalents | 51.80%187.17M | --187.17M | 207.72%123.31M | --123.31M | -12.82%40.07M | 21.77%45.96M | --37.75M |
| End period cash equivalent | 47.66%300.6M | --213.06M | 51.80%187.17M | --203.58M | 207.72%123.31M | -12.82%40.07M | --45.96M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified opinion | -- | Unqualified opinion | Unqualified opinion | Unqualified opinion |
| Auditor | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | Lixin Certified Public Accountants (Special General Partnership) | Lixin Certified Public Accountants (Special General Partnership) | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data